Malignant involvement of the iliopsoas muscle associated with non‐small cell lung cancer: Two case reports

Abstract

Key Clinical Message Under the current progression of molecular targeting or immune therapy, early detection and radiation therapy of iliopsoas metastasis will not only improve performance status but also enable the continuation of effective systemic cancer treatment.

Keywords

• ALK inhibitors
• malignant psoas syndrome (MPS)
• non‐small cell lung cancer (NSCLC)
• pembrolizumab
• radiation therapy